Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Immune Checkpoint Agents market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immune Checkpoint Agentsmarket, defines the market attractiveness level of Immune Checkpoint Agents market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immune Checkpoint Agents industry, describes the types of Immune Checkpoint Agents market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immune Checkpoint Agents market and the development prospects and opportunities of Immune Checkpoint Agents industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immune Checkpoint Agents market in Chapter 13.
By Player:
Bristol Myers Squibb
AstraZeneca
Roche
Merck
By Type:
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
By End-User:
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immune Checkpoint Agents Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immune Checkpoint Agents Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immune Checkpoint Agents Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immune Checkpoint Agents Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immune Checkpoint Agents Market Analysis and Outlook to 2022
-
7.1 Global Immune Checkpoint Agents Consumption (2017-2022)
-
7.2 United States Immune Checkpoint Agents Consumption (2017-2022)
-
7.3 Europe Immune Checkpoint Agents Consumption (2017-2022)
-
7.4 China Immune Checkpoint Agents Consumption (2017-2022)
-
7.5 Japan Immune Checkpoint Agents Consumption (2017-2022)
-
7.6 India Immune Checkpoint Agents Consumption (2017-2022)
-
7.7 South Korea Immune Checkpoint Agents Consumption (2017-2022)
8 Region and Country-wise Immune Checkpoint Agents Market Analysis and Outlook to 2028
-
8.1 Global Immune Checkpoint Agents Consumption Forecast (2022-2028)
-
8.2 United States Immune Checkpoint Agents Consumption Forecast (2022-2028)
-
8.3 Europe Immune Checkpoint Agents Consumption Forecast (2022-2028)
-
8.4 China Immune Checkpoint Agents Consumption Forecast (2022-2028)
-
8.5 Japan Immune Checkpoint Agents Consumption Forecast (2022-2028)
-
8.6 India Immune Checkpoint Agents Consumption Forecast (2022-2028)
-
8.7 South Korea Immune Checkpoint Agents Consumption Forecast (2022-2028)
9 Global Immune Checkpoint Agents Market Outlook by Types and Applications to 2022
-
9.1 Global Immune Checkpoint Agents Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-PD-L1 Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-PD-1 Drug Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CTLA4 Consumption and Growth Rate (2017-2022)
-
9.2 Global Immune Checkpoint Agents Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Blood Cancers Consumption and Growth Rate (2017-2022)
10 Global Immune Checkpoint Agents Market Outlook by Types and Applications to 2028
-
10.1 Global Immune Checkpoint Agents Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-PD-L1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-PD-1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CTLA4 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immune Checkpoint Agents Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Blood Cancers Consumption Forecast and Growth Rate (2022-2028)
11 Global Immune Checkpoint Agents Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immune Checkpoint Agents Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immune Checkpoint Agents Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immune Checkpoint Agents Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immune Checkpoint Agents Market Competitive Analysis
-
14.1 Bristol Myers Squibb
-
14.1.1 Bristol Myers Squibb Company Details
-
14.1.2 Bristol Myers Squibb Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol Myers Squibb Immune Checkpoint Agents Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Immune Checkpoint Agents Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Immune Checkpoint Agents Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Immune Checkpoint Agents Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immune Checkpoint Agents
-
Figure Immune Checkpoint Agents Picture
-
Table Global Immune Checkpoint Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immune Checkpoint Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immune Checkpoint Agents Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immune Checkpoint Agents Consumption by Country (2017-2022)
-
Figure United States Immune Checkpoint Agents Consumption and Growth Rate (2017-2022)
-
Table Europe Immune Checkpoint Agents Consumption and Growth Rate (2017-2022)
-
Figure China Immune Checkpoint Agents Consumption and Growth Rate (2017-2022)
-
Figure Japan Immune Checkpoint Agents Consumption and Growth Rate (2017-2022)
-
Figure India Immune Checkpoint Agents Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immune Checkpoint Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Checkpoint Agents Consumption Forecast by Country (2022-2028)
-
Figure United States Immune Checkpoint Agents Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immune Checkpoint Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immune Checkpoint Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immune Checkpoint Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immune Checkpoint Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immune Checkpoint Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-PD-L1 Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-PD-1 Drug Consumption and Growth Rate (2017-2022)
-
Figure Global CTLA4 Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancers Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-PD-L1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-PD-1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTLA4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immune Checkpoint Agents Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immune Checkpoint Agents Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Immune Checkpoint Agents Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Immune Checkpoint Agents Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Immune Checkpoint Agents Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Immune Checkpoint Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Immune Checkpoint Agents Product and Service
-
